In those countries where Vagi C® is registered as a medicinal product it is approved for:
In those countries where it is registered as a medical device the product is indicated for the normalization of the vaginal pH.
Vagi C® is designed to provide a natural protection of the vaginal micro-environment through the maintenance or restauration of the physiological pH. The application of Vagi C® rapidly renders the vaginal environment unsuitable to the growth of undesirable anaerobes, which are responsible for the development of bacterial vaginosis, also during pregnancy. Vagi C® helps in the treatment and prevention of bacterial vaginosis. It is particularly useful in patients with relapses and as follow-up to traditional antibiotics.
Last update: November 25, 2014 at 02:19 PM